Therapeutic agent for ocular fundus disease

Abstract

Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.

What is claimed is: 
     
         1 . A method of preventing or treating ocular fundus disease comprising:
 administering an agent comprising (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof to a subject in need thereof.   
     
     
         2 . The method according to  claim 1 , wherein the ocular fundus disease is diabetic retinopathy. 
     
     
         3 . The method according to  claim 1 , wherein the ocular fundus disease is diabetic macular edema. 
     
     
         4 . The method according to  claim 1 , wherein the ocular fundus disease is age-related macular degeneration. 
     
     
         5 . The method according to  claim 1 , wherein the agent is an ophthalmic preparation. 
     
     
         6 . The method according to  claim 1 , wherein administration of the agent is performed by ocular instillation. 
     
     
         7 . The method according to  claim 2 , wherein administration of the agent is performed by ocular instillation. 
     
     
         8 . The method according to  claim 3 , wherein administration of the agent is performed by ocular instillation. 
     
     
         9 . The method according to  claim 4 , wherein administration of the agent is performed by ocular instillation.